AVECTAS Leads €7.23 million Consortium Awarded Part Funding From Ireland’s Disruptive Technologies Innovation Fund
Funding to develop high throughput cell engineering technology to manufacture off the shelf cell therapies
Project, led by Avectas in partnership with Bluebridge Technologies and National Institute for Bioprocessing Research and Training (NIBRT), would support Ireland s goal of being at the forefront of cell therapy manufacturing
Kildare, Ireland and Cambridge, MA, USA … Friday 23 April 2021. Irish cell engineering company, Avectas, is leading a consortium which will invest €7.23 million, including €4.4 million awarded under the Irish Government’s Disruptive Technology Innovation Fund (DTIF), to develop a high-throughput scale of its proprietary cell engineering platform Solupore®. With consortium partners Bluebridge Technologies and NIBRT, the project expands Avectas development towards commercialising an advanced large-scale, digitalised cell engin
Ninth Level Ireland » Blog Archive » Irish Universities secure over €80m with their industry partners to develop ground-breaking disruptive technologies
9thlevel.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 9thlevel.ie Daily Mail and Mail on Sunday newspapers.
Ninth Level Ireland » Leo Varadkhar
9thlevel.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 9thlevel.ie Daily Mail and Mail on Sunday newspapers.